Search Results - J. Cavenagh

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    S128: A RANDOMISED COMPARISON OF CPX-351 AND FLAG-IDA IN HIGH RISK ACUTE MYELOID LEUKAEMIA. RESULTS FROM THE NCRI AML19 TRIAL

    S128: A RANDOMISED COMPARISON OF CPX-351 AND FLAG-IDA IN HIGH RISK ACUTE MYELOID LEUKAEMIA. RESULTS FROM THE NCRI AML19 TRIAL by N. Russell, C. Wilhelm-Benartzi, S. Knapper, L. Batten, J Canham, E. Hinson, U. Malthe Overgaard, J. Othman, R. Dillon, P. Mehta, P. Kottaridis, J. Cavenagh, C. Hemmaway, C. Arnold, M. Dennis

    Published 2022-06-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    S126: GEMTUZUMAB-BASED INDUCTION CHEMOTHERAPY COMBINED WITH MIDOSTAURIN FOR FLT3 MUTATED AML. RESULTS FROM THE NCRI AML19 “MIDOTARG” PILOT TRIAL

    S126: GEMTUZUMAB-BASED INDUCTION CHEMOTHERAPY COMBINED WITH MIDOSTAURIN FOR FLT3 MUTATED AML. RESULTS FROM THE NCRI AML19 “MIDOTARG” PILOT TRIAL by N. Russell, C. Wilhelm-Benartzi, J. Othman, R. Dillon, N. Potter, J. Jovanovic, A. Gilkes, L. M. Batten, J. Canham, E. L. Hinson, P. Kottaridis, J. Cavenagh, C. Arnold, M. Dennis, S. Knapper

    Published 2022-06-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: